DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0678222 | Breast Carcinoma | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0006142 | Malignant neoplasm of breast | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0006826 | Malignant Neoplasms | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0009375 | Colonic Neoplasms | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0279626 | Squamous cell carcinoma of esophagus | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0040136 | Thyroid Neoplasm | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C1332977 | Childhood Leukemia | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0346647 | Malignant neoplasm of pancreas | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0235974 | Pancreatic carcinoma | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0013080 | Down Syndrome | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0033845 | Pseudotumor Cerebri | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0040128 | Thyroid Diseases | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0007102 | Malignant tumor of colon | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0007115 | Malignant neoplasm of thyroid | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0023418 | leukemia | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | NUDT5 | 11164 | nudix hydrolase 5 | Q9UKK9 |
C1306459 | Primary malignant neoplasm | NUDT5 | 11164 | nudix hydrolase 5 | Q9UKK9 |
C0006826 | Malignant Neoplasms | NUDT5 | 11164 | nudix hydrolase 5 | Q9UKK9 |
C0027651 | Neoplasms | NUDT5 | 11164 | nudix hydrolase 5 | Q9UKK9 |
C0006142 | Malignant neoplasm of breast | NUDT5 | 11164 | nudix hydrolase 5 | Q9UKK9 |
C0020505 | Hyperphagia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0234533 | Generalized seizures | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0010495 | Cutis Laxa | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0023895 | Liver diseases | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024